Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study - ScienceDirect
ELIQUIS® (apixaban) dosing | patients with renal or hepatic impairment | ELIQUIS IRELAND
Apixaban Dose Adjustments in Atrial Fibrillation - ... | GrepMed
Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study - ScienceDirect
Aspirin and an oral anticoagulant – can they be used together? - NPS MedicineWise
Apixaban Concentrations in Routine Clinical Care of Older Adults With Nonvalvular Atrial Fibrillation - ScienceDirect
ELIQUIS® (apixaban) dosing | patients with renal or hepatic impairment | ELIQUIS UK
Eliquis Full Prescribing Information, Dosage & Side Effects | MIMS Malaysia
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer | NEJM
Cureus | Comparison of the Efficacy and Safety of Apixaban and Warfarin in the Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation: A Meta-Analysis | Article
PDF) The Role of Apixaban for Venous and Arterial Thromboembolic Disease
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer | NEJM
Cureus | Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review | Article
DVT Prophylaxis After Hip/Knee Surgery|ELIQUIS® (apixaban) Safety Info
Table 1 from Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical
Frontiers | Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease
Apixaban concentrations in elderly NVAF patients: is less enough? | Geriatrics
Eliquis in the Management of NVAF and VTE - ppt download
Eliquis Full Prescribing Information, Dosage & Side Effects | MIMS Malaysia
Target-Specific Oral Anticoagulants
apixaban monograph
Outcomes After Use of Standard- and Low-Dose Non–Vitamin K Oral Anticoagulants in Asian Patients With Atrial Fibrillation | Stroke
These highlights do not include all the information needed to use ELIQUIS safely and effectively. See full prescribing information for ELIQUIS. ELIQUIS® (apixaban) tablets, for oral useInitial U.S. Approval: 2012
ELIQUIS® (apixaban) dosing | patients with renal or hepatic impairment | ELIQUIS UK
Table 1 from Role of apixaban (eliquis) in the treatment and prevention of thromboembolic disease. | Semantic Scholar
